AIKI's logo.
Ticker Symbol: AIKI

AIkido Pharma Inc

$0.76 - 02-10-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000012239

Company Profile

AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.

Sector: Professional, Scientific, and Technical Services
Industry: Payroll Services
Standard Industrial Classification Code (SIC code): 8731
Address: One Rockefeller Plaza, 11Th Floor
CEO: Anthony Hayes
Tags:
  • Health Technology
  • Biotechnology
  • Professional, Scientific, and Technical Services
  • Payroll Services

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: $3.28 - $3.28
Beta: 0.92
52wk. High: $11.48
52wk. Low: $3.31
Ytd. Change -64.33%
50 Day Moving Average: $4.00
200 Day Moving Average: $5.61
Shares Outstanding: 5485096

Valuation

Market Cap: 1.8B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A